Effective strategies for managing new Pseudomonas cultures in adults with cystic fibrosis

Eur Respir J. 2015 Sep;46(3):862-5. doi: 10.1183/09031936.00225914. Epub 2015 Apr 16.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Analysis of Variance
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Chi-Square Distribution
  • Ciprofloxacin / pharmacology
  • Ciprofloxacin / therapeutic use
  • Cohort Studies
  • Colistin / pharmacology
  • Colistin / therapeutic use
  • Confidence Intervals
  • Culture Media, Conditioned
  • Cystic Fibrosis / drug therapy*
  • Cystic Fibrosis / microbiology*
  • Cystic Fibrosis / physiopathology
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Pseudomonas Infections / diagnosis
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / isolation & purification
  • Retrospective Studies
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Culture Media, Conditioned
  • Ciprofloxacin
  • Colistin